These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 16023516)

  • 1. Attention-deficit hyperactivity disorder.
    Biederman J; Faraone SV
    Lancet; 2005 Jul 16-22; 366(9481):237-48. PubMed ID: 16023516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.
    Laucht M; Skowronek MH; Becker K; Schmidt MH; Esser G; Schulze TG; Rietschel M
    Arch Gen Psychiatry; 2007 May; 64(5):585-90. PubMed ID: 17485610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention-deficit/hyperactivity disorder: a selective overview.
    Biederman J
    Biol Psychiatry; 2005 Jun; 57(11):1215-20. PubMed ID: 15949990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD).
    Sharma A; Couture J
    Ann Pharmacother; 2014 Feb; 48(2):209-25. PubMed ID: 24259638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses.
    Genro JP; Kieling C; Rohde LA; Hutz MH
    Expert Rev Neurother; 2010 Apr; 10(4):587-601. PubMed ID: 20367210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Background, clinical features and treatment of attention deficit hyperactivity disorder in children.
    Warikoo N; Faraone SV
    Expert Opin Pharmacother; 2013 Oct; 14(14):1885-906. PubMed ID: 23865438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention-deficit hyperactivity disorder.
    Calis KA; Grothe DR; Elia J
    Clin Pharm; 1990 Aug; 9(8):632-42. PubMed ID: 1974836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alterations in the pattern of dopaminergic markers in attention-deficit/hyperactivity disorder].
    Díaz-Heijtz R; Mulas F; Forssberg H
    Rev Neurol; 2006 Feb; 42 Suppl 2():S19-23. PubMed ID: 16555214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities.
    Kaufmann R; Goldberg-Stern H; Shuper A
    J Child Neurol; 2009 Jun; 24(6):727-33. PubMed ID: 19491115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental risk factors for attention-deficit hyperactivity disorder.
    Banerjee TD; Middleton F; Faraone SV
    Acta Paediatr; 2007 Sep; 96(9):1269-74. PubMed ID: 17718779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology.
    Spencer TJ; Biederman J; Mick E
    J Pediatr Psychol; 2007 Jul; 32(6):631-42. PubMed ID: 17556405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurobiology of attention deficit/hyperactivity disorder].
    Purper-Ouakil D; Lepagnol-Bestel AM; Grosbellet E; Gorwood P; Simonneau M
    Med Sci (Paris); 2010 May; 26(5):487-96. PubMed ID: 20510147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-deficit/hyperactivity disorder: an update.
    Pary R; Lewis S; Matuschka PR; Lippmann S
    South Med J; 2002 Jul; 95(7):743-9. PubMed ID: 12144081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary and alternative medical therapies for children with attention-deficit/hyperactivity disorder (ADHD).
    Pellow J; Solomon EM; Barnard CN
    Altern Med Rev; 2011 Dec; 16(4):323-37. PubMed ID: 22214252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults.
    Ramos-Quiroga JA; Nasillo V; Fernández-Aranda F; Casas M
    Expert Rev Neurother; 2014 May; 14(5):553-67. PubMed ID: 24738746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead and Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms: a meta-analysis.
    Goodlad JK; Marcus DK; Fulton JJ
    Clin Psychol Rev; 2013 Apr; 33(3):417-25. PubMed ID: 23419800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.